MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1761 to 1780 of 166,322 approvalsPage 89 of 8317

Trifluridine and Tipiracil Hydrochloride Tablets

Approval Number: 国药准字H20253171
Registration: Jan 14, 2025

Biapenem for Injection

Approval Number: 国药准字H20253173
Registration: Jan 14, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20253128
Registration: Jan 14, 2025

Bromfenac Sodium Eye Drops

Approval Number: 国药准字H20253220
Registration: Jan 14, 2025

Bromfenac Sodium Eye Drops

Approval Number: 国药准字H20253221
Registration: Jan 14, 2025

Vortioxetine Hydrobromide Tablets

Approval Number: 国药准字H20253190
Registration: Jan 14, 2025

Etoricoxib Tablets

Approval Number: 国药准字H20253148
Registration: Jan 14, 2025

Ursodeoxycholic Acid Capsules

Approval Number: 国药准字H20253177
Registration: Jan 14, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20253219
Registration: Jan 14, 2025

Levofloxacin Oral Solution

Approval Number: 国药准字H20253126
Registration: Jan 14, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253138
Registration: Jan 14, 2025

Tobramycin Eye Drops

Approval Number: 国药准字H20253197
Registration: Jan 14, 2025

Oseltamivir Phosphate Granules

Approval Number: 国药准字H20253139
Registration: Jan 14, 2025

Rebamipide Tablets

Approval Number: 国药准字H20253187
Registration: Jan 14, 2025

Cefprozil for Suspension

Approval Number: 国药准字H20253211
Registration: Jan 14, 2025

Apalutamide Tablets

Approval Number: 国药准字H20253127
Registration: Jan 14, 2025

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number: 国药准字H20253199
Registration: Jan 14, 2025

Phloroglucinol Orally Disintegrating Tablets

Approval Number: 国药准字H20253134
Registration: Jan 14, 2025

甲丙氨酯

Approval Number: 国药准字H14021794
Registration: Jan 13, 2025

盐酸氯胺酮

Approval Number: 国药准字H14021800
Registration: Jan 13, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.